FDA Inspection
Alison R. Sehgal, MDAlison R. Sehgal, MD – FDA Inspection, Dec 29, 2020
Record Details
This FDA Inspection record concerns Alison R. Sehgal, MD, with an inspection on December 29, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Alison R. Sehgal, MD
- Inspection Date
- December 29, 2020
- Product Type
- Biologics
View Company Profile
ID · aef577b3-d3f1-43c4-8a7d-8e6c946bc6c6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1134296
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Alison R. Sehgal, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 22, 2022 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Alison R. Sehgal, MD
- FDA Inspection 1168169 - 2022-04-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.